Medicare Enrolled

Dr. Luke Bolek, MD

Nuclear Medicine · Miami, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
8932 SW 97H AVE, Miami, FL 33176
3052435512
In practice since 2007 (19 years)
NPI: 1508992470 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bolek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bolek? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bolek

Dr. Luke Bolek is a nuclear medicine in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bolek performed 810 Medicare services across 560 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bolek received a total of $223 from 2 pharmaceutical and/or device companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bolek is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 810 Medicare services$ $223 industry payments

Medicare Practice Summary

Medicare Utilization ↗
810
Medicare services
Bottom 32% in FL for nuclear medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
560
Unique beneficiaries
$702
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie281$796$1,038
Nuclear medicine study from skull base to mid-thigh with ct scan277$834$5,337
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries167$410$527
Nuclear medicine study whole body with ct scan46$954$5,964
Nuclear medicine studies of heart muscle at rest and with stress and spect23$61$275
Bone density scan (DEXA)16$10$39
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2018 ↗
$223
Total received (2018-2018)
Top 46% in FL for nuclear medicine
2
Companies
3
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$223 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2018
$223

Payments by company (2018)

Consulting
Speaking
Meals & Travel
Research
Advanced Accelerator Applications
$211
Astellas Pharma US Inc
$12
Top 3 companies account for 100.0% of total payments
Associated products mentioned in payments ›
LEXISCAN · LUTATHERA (lutetium Lu 177 dotatate)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $28 per 100 Medicare services performed
Looking for a nuclear medicine in Miami?
Compare nuclear medicines in the Miami area by procedure volume, costs, and industry payment transparency.
Browse nuclear medicines nearby

Geographic Context

Nuclear Medicines within 10 mi
10
Per 100K population
0.4
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data✓ Medicare Util.Annual (CY lag)
Industry Payments✓ Open PaymentsCY 2018
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bolek is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bolek experienced with gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie?
Based on Medicare claims data, Dr. Bolek performed 281 gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bolek receive payments from pharmaceutical companies?
Yes. Dr. Bolek received a total of $223 from 2 companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bolek's costs compare to other nuclear medicines in Miami?
Dr. Bolek's average Medicare payment per service is $702. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bolek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Nuclear Medicines in Miami
Browse nuclear medicines in Miami ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Medicines in FL
Nuclear Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Medicines in FL
Which FL nuclear medicines receive the most from drug and device companies.
By company
Advanced Accelerator Applications Payments to Doctors
See all physicians who received payments from Advanced Accelerator Applications.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →